Your browser doesn't support javascript.
loading
[Mechanisms and prevention strategies of relapse and resistance after BCMA-CAR-T cell in multiple myeloma].
Zhang, L; Wang, Y; Xu, K L.
Affiliation
  • Zhang L; Blood Diseases Institute, Xuzhou Medical University; Department of Hematology, the Affiliated Hospital of Xuzhou Medical University; Key Laboratory of Bone Marrow Stem Cell, Xuzhou 221002, China.
  • Wang Y; Blood Diseases Institute, Xuzhou Medical University; Department of Hematology, the Affiliated Hospital of Xuzhou Medical University; Key Laboratory of Bone Marrow Stem Cell, Xuzhou 221002, China.
  • Xu KL; Blood Diseases Institute, Xuzhou Medical University; Department of Hematology, the Affiliated Hospital of Xuzhou Medical University; Key Laboratory of Bone Marrow Stem Cell, Xuzhou 221002, China.
Zhonghua Xue Ye Xue Za Zhi ; 42(9): 778-781, 2021 09 14.
Article in Zh | MEDLINE | ID: mdl-34753237
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Receptors, Chimeric Antigen / Multiple Myeloma Limits: Humans Language: Zh Journal: Zhonghua Xue Ye Xue Za Zhi Year: 2021 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Receptors, Chimeric Antigen / Multiple Myeloma Limits: Humans Language: Zh Journal: Zhonghua Xue Ye Xue Za Zhi Year: 2021 Document type: Article Affiliation country: Country of publication: